Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Hoffmann-Vold

Showing results (11-20 of 165) with videos related to

Pageof 17
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2019
ReplyAnna-Maria Hoffmann-Vold, Henriette Didriksen, Øyvind Molberg
The Lancet. Respiratory Medicine|September 9, 2021
Interstitial lung diseases: quo vadis?Michael Kreuter, Anna-Maria Hoffmann-Vold, Elisabeth Bendstrup
The Lancet. Rheumatology|January 26, 2024
European consensus statements for interstitial lung disease in systemic sclerosis - Authors' replyAnna-Maria Hoffmann-Vold, Toby M Maher, Oliver Distler
Rheumatic Diseases Clinics of North America|April 7, 2023
Scleroderma Skin: How Is Treatment Best Guided by Data and Implemented in Clinical Practice?Madelon C Vonk, Shervin Assassi, Anna-Maria Hoffmann-Vold
American Journal of Respiratory and Critical Care Medicine|October 6, 2025
ILA or ILD in CTD: The Alphabet Soup ContinuesCatharina C Moor, Michael Kreuter, Anna-Maria Hoffmann-Vold
Annals of the Rheumatic Diseases|January 20, 2026
Correspondence on the 'ERS/EULAR 2025 CTD-ILD Guideline: Queries from an Indian Perspective' and on the 'ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease' by Antoniou et al.'Anna-Maria Hoffmann-Vold, Katerina Antoniou, Oliver Distler, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Circulating biomarkers of systemic sclerosis - interstitial lung diseaseAnna-Maria Hoffmann-Vold, Håvard Fretheim, Chantal Meier, et al.
Expert Review of Clinical Immunology|December 21, 2019
The potential of fecal microbiota transplantation in systemic sclerosisAnna-Maria Hoffmann-Vold, Håvard Fretheim, Henriette Didriksen, et al.
The European Respiratory Journal|April 2, 2026
Reply on behalf of the ERS/EULAR task force for connective tissue disease-associated interstitial lung diseaseAnna-Maria Hoffmann-Vold, Katerina Antoniou, Oliver Distler, et al.
Current Opinion in Pulmonary Medicine|July 20, 2022
Recent advances in the management of systemic sclerosis-associated interstitial lung diseaseAnna-Maria Hoffmann-Vold, Oliver Distler, Bruno Crestani, et al.
Pageof 17

Showing results (11-20 of 165) with videos related to

Sort By:
Pageof 17
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2019
ReplyAnna-Maria Hoffmann-Vold, Henriette Didriksen, Øyvind Molberg
The Lancet. Respiratory Medicine|September 9, 2021
Interstitial lung diseases: quo vadis?Michael Kreuter, Anna-Maria Hoffmann-Vold, Elisabeth Bendstrup
The Lancet. Rheumatology|January 26, 2024
European consensus statements for interstitial lung disease in systemic sclerosis - Authors' replyAnna-Maria Hoffmann-Vold, Toby M Maher, Oliver Distler
Rheumatic Diseases Clinics of North America|April 7, 2023
Scleroderma Skin: How Is Treatment Best Guided by Data and Implemented in Clinical Practice?Madelon C Vonk, Shervin Assassi, Anna-Maria Hoffmann-Vold
American Journal of Respiratory and Critical Care Medicine|October 6, 2025
ILA or ILD in CTD: The Alphabet Soup ContinuesCatharina C Moor, Michael Kreuter, Anna-Maria Hoffmann-Vold
Annals of the Rheumatic Diseases|January 20, 2026
Correspondence on the 'ERS/EULAR 2025 CTD-ILD Guideline: Queries from an Indian Perspective' and on the 'ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease' by Antoniou et al.'Anna-Maria Hoffmann-Vold, Katerina Antoniou, Oliver Distler, et al.
Journal of Scleroderma and Related Disorders|April 6, 2022
Circulating biomarkers of systemic sclerosis - interstitial lung diseaseAnna-Maria Hoffmann-Vold, Håvard Fretheim, Chantal Meier, et al.
Expert Review of Clinical Immunology|December 21, 2019
The potential of fecal microbiota transplantation in systemic sclerosisAnna-Maria Hoffmann-Vold, Håvard Fretheim, Henriette Didriksen, et al.
The European Respiratory Journal|April 2, 2026
Reply on behalf of the ERS/EULAR task force for connective tissue disease-associated interstitial lung diseaseAnna-Maria Hoffmann-Vold, Katerina Antoniou, Oliver Distler, et al.
Current Opinion in Pulmonary Medicine|July 20, 2022
Recent advances in the management of systemic sclerosis-associated interstitial lung diseaseAnna-Maria Hoffmann-Vold, Oliver Distler, Bruno Crestani, et al.
Pageof 17